08:03:58 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-03-07 Kvartalsrapport 2024-Q2
2023-11-17 Ordinarie utdelning HEALTH 0.00 EUR
2023-11-16 Årsstämma 2024
2023-09-28 Bokslutskommuniké 2023
2023-04-24 Extra Bolagsstämma 2023
2023-03-23 Kvartalsrapport 2023-Q2
2022-11-17 Årsstämma 2023
2022-10-25 Ordinarie utdelning HEALTH 0.00 EUR
2022-09-29 Bokslutskommuniké 2022
2022-06-29 Extra Bolagsstämma 2022
2022-02-24 Kvartalsrapport 2022-Q2
2021-10-29 Ordinarie utdelning HEALTH 0.00 EUR
2021-10-28 Årsstämma 2022
2021-09-15 Bokslutskommuniké 2021

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Nightingale Health är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling av medicintekniska produkter. Produktportföljen är bred och inkluderar plattformar och tjänster inom blodanalyser som används i sjukdomsförebyggande syfte. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs globalt med störst närvaro inom Europa.
2021-03-24 08:30:00

Nightingale Health Plc - Managers' transactions - 24 March 2021 9:30 a.m. (Finnish time)

Nightingale Health Plc - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Soininen, Timo

Position: Member of the Board/Deputy member

Issuer: Nightingale Health Oyj

LEI: 743700WUIPC24LVMLO66

Notification type: INITIAL NOTIFICATION

Reference number: 743700WUIPC24LVMLO66_20210323193901_3

____________________________________________

Transaction date: 2021-03-23

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000490875

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 88 Unit price: 5 EUR

(2): Volume: 244 Unit price: 5 EUR

(3): Volume: 237 Unit price: 5 EUR

(4): Volume: 229 Unit price: 5 EUR

(5): Volume: 212 Unit price: 5 EUR

(6): Volume: 1,373 Unit price: 5 EUR

(7): Volume: 236 Unit price: 5 EUR

(8): Volume: 126 Unit price: 5 EUR

(9): Volume: 981 Unit price: 5 EUR

(10): Volume: 2,054 Unit price: 5 EUR

(11): Volume: 946 Unit price: 5 EUR

(12): Volume: 260 Unit price: 5 EUR

(13): Volume: 461 Unit price: 5 EUR

(14): Volume: 949 Unit price: 5 EUR

(15): Volume: 682 Unit price: 5 EUR

(16): Volume: 270 Unit price: 5 EUR

(17): Volume: 1,152 Unit price: 5 EUR

Aggregated transactions

(17): Volume: 10,500 Volume weighted average price: 5 EUR

For further information, please contact:

Teemu Suna, CEO
ir@nightingalehealth.com,tel. +358 20 730 1810

Certified Adviser:
Oaklins Merasco Ltd, tel. +358 9 6129 670

About Nightingale

Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. By combining our pioneering blood-testing technology and the ability to detect future disease risks, we are creating a world-leading health data platform that enables preventative care with better information. The platform helps people make better personal health decisions and connects the health industry to offer their services for individuals' preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone.